Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer.

Oncoimmunology

Sarhan D, Leijonhufvud C, Murray S, Witt K, Seitz C, Wallerius M, Xie H, Ullén A, Harmenberg U, Lidbrink E, Rolny C, Andersson J, Lundqvist A.
PMID: 28920001
Oncoimmunology. 2017 Jun 14;6(8):e1338238. doi: 10.1080/2162402X.2017.1338238. eCollection 2017.

Regulatory T cells (Treg) suppress anti-tumor immune responses and their infiltration in the tumor microenvironment is associated with inferior prognosis in cancer patients. Thus, in order to enhance anti-tumor immune responses, selective depletion of Treg is highly desired. We...

Cite
Sarhan D, Leijonhufvud C, Murray S, et al. Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer. Oncoimmunology. 2017;6(8):e1338238doi: 10.1080/2162402X.2017.1338238.
Sarhan, D., Leijonhufvud, C., Murray, S., Witt, K., Seitz, C., Wallerius, M., Xie, H., Ullén, A., Harmenberg, U., Lidbrink, E., Rolny, C., Andersson, J., & Lundqvist, A. (2017). Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer. Oncoimmunology, 6(8), e1338238. https://doi.org/10.1080/2162402X.2017.1338238
Sarhan, Dhifaf, et al. "Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer." Oncoimmunology vol. 6,8 (2017): e1338238. doi: https://doi.org/10.1080/2162402X.2017.1338238
Sarhan D, Leijonhufvud C, Murray S, Witt K, Seitz C, Wallerius M, Xie H, Ullén A, Harmenberg U, Lidbrink E, Rolny C, Andersson J, Lundqvist A. Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer. Oncoimmunology. 2017 Jun 14;6(8):e1338238. doi: 10.1080/2162402X.2017.1338238. eCollection 2017. PMID: 28920001; PMCID: PMC5593706.
Copy Download .nbib Format: NLM
Depolarization-induced release of [(3)H]histamine by high potassium concentrations, electrical stimulation and veratrine from rat brain slices after incubation with the radiolabelled amine.

Neurochemistry international

Mulder AH, van Amsterdam RG, Wilbrink M, Schoffelmeer AN.
PMID: 20487952
Neurochem Int. 1983;5(3):291-7. doi: 10.1016/0197-0186(83)90031-1.

Brain slices obtained from neocortex, hypothalamus or hippocampus were incubated with [(3)H]histamine and subsequently superfused and exposed to different depolarizing stimuli, viz. high K(+)-concentrations, electrical field stimulation and veratrine. K(+)-induced release of tritium was completely calcium-dependent and its magnitude...

Cite
Mulder AH, van Amsterdam RG, Wilbrink M, et al. Depolarization-induced release of [(3)H]histamine by high potassium concentrations, electrical stimulation and veratrine from rat brain slices after incubation with the radiolabelled amine. Neurochem Int. 1983;5(3):291-7doi: 10.1016/0197-0186(83)90031-1.
Mulder, A. H., van Amsterdam, R. G., Wilbrink, M., & Schoffelmeer, A. N. (1983). Depolarization-induced release of [(3)H]histamine by high potassium concentrations, electrical stimulation and veratrine from rat brain slices after incubation with the radiolabelled amine. Neurochemistry international, 5(3), 291-7. https://doi.org/10.1016/0197-0186(83)90031-1
Mulder, A H, et al. "Depolarization-induced release of [(3)H]histamine by high potassium concentrations, electrical stimulation and veratrine from rat brain slices after incubation with the radiolabelled amine." Neurochemistry international vol. 5,3 (1983): 291-7. doi: https://doi.org/10.1016/0197-0186(83)90031-1
Mulder AH, van Amsterdam RG, Wilbrink M, Schoffelmeer AN. Depolarization-induced release of [(3)H]histamine by high potassium concentrations, electrical stimulation and veratrine from rat brain slices after incubation with the radiolabelled amine. Neurochem Int. 1983;5(3):291-7. doi: 10.1016/0197-0186(83)90031-1. PMID: 20487952.
Copy Download .nbib Format: NLM
On the specificity of 6-hydroxydopamine-induced degeneration of central noradrenaline neurons after intracerebral injection.

Neuroscience letters

Lidbrink P, Jonsson G.
PMID: 19604749
Neurosci Lett. 1975 Jul;1(1):35-9. doi: 10.1016/0304-3940(75)90009-9.

No abstract available.

Cite
Lidbrink P, Jonsson G. On the specificity of 6-hydroxydopamine-induced degeneration of central noradrenaline neurons after intracerebral injection. Neurosci Lett. 1975;1(1):35-9doi: 10.1016/0304-3940(75)90009-9.
Lidbrink, P., & Jonsson, G. (1975). On the specificity of 6-hydroxydopamine-induced degeneration of central noradrenaline neurons after intracerebral injection. Neuroscience letters, 1(1), 35-9. https://doi.org/10.1016/0304-3940(75)90009-9
Lidbrink, P, and Jonsson, G. "On the specificity of 6-hydroxydopamine-induced degeneration of central noradrenaline neurons after intracerebral injection." Neuroscience letters vol. 1,1 (1975): 35-9. doi: https://doi.org/10.1016/0304-3940(75)90009-9
Lidbrink P, Jonsson G. On the specificity of 6-hydroxydopamine-induced degeneration of central noradrenaline neurons after intracerebral injection. Neurosci Lett. 1975 Jul;1(1):35-9. doi: 10.1016/0304-3940(75)90009-9. PMID: 19604749.
Copy Download .nbib Format: NLM
Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study.

Clinical sarcoma research

Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M.
PMID: 33292545
Clin Sarcoma Res. 2020 Nov 17;10(1):22. doi: 10.1186/s13569-020-00145-5.

BACKGROUND: We recently reported outcomes from a Scandinavian Sarcoma Group adjuvant study (SSG XX group A) conducted on localized and operable high risk soft tissue sarcoma (STS) of the extremities and trunk wall. SSG XX, group B, comprised of...

Cite
Hall KS, Bruland ØS, Bjerkehagen B, et al. Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study. Clin Sarcoma Res. 2020;10(1):22doi: 10.1186/s13569-020-00145-5.
Hall, K. S., Bruland, �. �. S., Bjerkehagen, B., Lidbrink, E., Jebsen, N., Hagberg, H., Papworth, K., Hagberg, O., Trovik, C., Bauer, H., & Eriksson, M. (2020). Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study. Clinical sarcoma research, 10(1), 22. https://doi.org/10.1186/s13569-020-00145-5
Hall, Kirsten Sundby, et al. "Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study." Clinical sarcoma research vol. 10,1 (2020): 22. doi: https://doi.org/10.1186/s13569-020-00145-5
Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M. Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study. Clin Sarcoma Res. 2020 Nov 17;10(1):22. doi: 10.1186/s13569-020-00145-5. PMID: 33292545; PMCID: PMC7672981.
Copy Download .nbib Format: NLM
[Subjective certainty to increase the acceptance of automated and connected driving].

Forschung im ingenieurwesen

Drewitz U, Wilbrink M, Oehl M, Jipp M, Ihme K.
PMID: 34230678
Forsch Ingenieurwes. 2021 Jul 02;1-16. doi: 10.1007/s10010-021-00500-y. Epub 2021 Jul 02.

An important factor for the acceptance and thus the spread of automated and connected driving (ACD) is the degree of subjective uncertainty that users experience when interacting with automated vehicles. Subjective uncertainties always occur when people are not able...

Cite
Drewitz U, Wilbrink M, Oehl M, et al. Subjektive Sicherheit zur Steigerung der Akzeptanz des automatisierten und vernetzten Fahrens. [Subjective certainty to increase the acceptance of automated and connected driving]. Forsch Ingenieurwes. 2021;1-16doi: 10.1007/s10010-021-00500-y.
Drewitz, U., Wilbrink, M., Oehl, M., Jipp, M., & Ihme, K. (2021). Subjektive Sicherheit zur Steigerung der Akzeptanz des automatisierten und vernetzten Fahrens. [Subjective certainty to increase the acceptance of automated and connected driving]. Forschung im ingenieurwesen, 1-16. https://doi.org/10.1007/s10010-021-00500-y
Drewitz, Uwe, et al. "Subjektive Sicherheit zur Steigerung der Akzeptanz des automatisierten und vernetzten Fahrens." [Subjective certainty to increase the acceptance of automated and connected driving]. Forschung im ingenieurwesen vol. (2021): 1-16. doi: https://doi.org/10.1007/s10010-021-00500-y
Drewitz U, Wilbrink M, Oehl M, Jipp M, Ihme K. Subjektive Sicherheit zur Steigerung der Akzeptanz des automatisierten und vernetzten Fahrens. [Subjective certainty to increase the acceptance of automated and connected driving]. Forsch Ingenieurwes. 2021 Jul 02;1-16. doi: 10.1007/s10010-021-00500-y. Epub 2021 Jul 02. German. PMID: 34230678; PMCID: PMC8250544.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries